DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Hofman MS, Lawrentschuk N, Francis RJ. et al; proPSMA Study Group Collaborators.
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study.
Lancet 2020;
395 (10231): 1208-1216
DOI: 10.1016/S0140-6736(20)30314-7.
We do not assume any responsibility for the contents of the web pages of other providers.